調査レポート | • レポートコード：GIR-2104Z04795 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エダラボンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エダラボンの種類別市場規模（経口、注射）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エダラボンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Mitsubishi Tanabe Pharma、Simcere、Taj Pharmaceuticals Ltd.、Sun Pharmaceutical Industries Ltd.、Unichem Laboratories Ltd、UCB India Ltd、Piramal Healthcare ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：病院、クリニック、その他 ・エダラボンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エダラボンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エダラボンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エダラボンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エダラボンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Edaravone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Edaravone size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Edaravone market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Edaravone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Edaravone market are listed below:
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Edaravone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Edaravone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Edaravone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Edaravone Market Size & Forecast
1.4.1 Global Edaravone Sales in Value (2016-2026))
1.4.2 Global Edaravone Sales in Volume (2016-2026)
1.4.3 Global Edaravone Price by Type (2016-2026) & (USD/Unit)
1.5 Global Edaravone Production Capacity Analysis
1.5.1 Global Edaravone Total Production Capacity (2016-2026)
1.5.2 Global Edaravone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Edaravone Market Drivers
1.6.2 Edaravone Market Restraints
1.6.3 Edaravone Trends Analysis
2 Manufacturers Profiles
2.1 Mitsubishi Tanabe Pharma
2.1.1 Mitsubishi Tanabe Pharma Details
2.1.2 Mitsubishi Tanabe Pharma Major Business
2.1.3 Mitsubishi Tanabe Pharma Edaravone Product and Services
2.1.4 Mitsubishi Tanabe Pharma Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Simcere
2.2.1 Simcere Details
2.2.2 Simcere Major Business
2.2.3 Simcere Edaravone Product and Services
2.2.4 Simcere Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Taj Pharmaceuticals Ltd.
2.3.1 Taj Pharmaceuticals Ltd. Details
2.3.2 Taj Pharmaceuticals Ltd. Major Business
2.3.3 Taj Pharmaceuticals Ltd. Edaravone Product and Services
2.3.4 Taj Pharmaceuticals Ltd. Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sun Pharmaceutical Industries Ltd.
2.4.1 Sun Pharmaceutical Industries Ltd. Details
2.4.2 Sun Pharmaceutical Industries Ltd. Major Business
2.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Product and Services
2.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Unichem Laboratories Ltd
2.5.1 Unichem Laboratories Ltd Details
2.5.2 Unichem Laboratories Ltd Major Business
2.5.3 Unichem Laboratories Ltd Edaravone Product and Services
2.5.4 Unichem Laboratories Ltd Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 UCB India Ltd
2.6.1 UCB India Ltd Details
2.6.2 UCB India Ltd Major Business
2.6.3 UCB India Ltd Edaravone Product and Services
2.6.4 UCB India Ltd Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Piramal Healthcare
2.7.1 Piramal Healthcare Details
2.7.2 Piramal Healthcare Major Business
2.7.3 Piramal Healthcare Edaravone Product and Services
2.7.4 Piramal Healthcare Edaravone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Edaravone Sales by Manufacturer
3.1 Global Edaravone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Edaravone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Edaravone
3.4 Market Concentration Rate
3.4.1 Top 3 Edaravone Manufacturer Market Share
3.4.2 Top 6 Edaravone Manufacturer Market Share
3.5 Global Edaravone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Edaravone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Edaravone Market Size by Region
4.1.1 Global Edaravone Sales in Volume by Region (2016-2026)
4.1.2 Global Edaravone Revenue by Region (2016-2026)
4.2 North America Edaravone Revenue (2016-2026)
4.3 Europe Edaravone Revenue (2016-2026)
4.4 Asia-Pacific Edaravone Revenue (2016-2026)
4.5 South America Edaravone Revenue (2016-2026)
4.6 Middle East and Africa Edaravone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Edaravone Sales in Volume by Type (2016-2026)
5.2 Global Edaravone Revenue by Type (2016-2026)
5.3 Global Edaravone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Edaravone Sales in Volume by Application (2016-2026)
6.2 Global Edaravone Revenue by Application (2016-2026)
6.3 Global Edaravone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Edaravone Sales by Type (2016-2026)
7.2 North America Edaravone Sales by Application (2016-2026)
7.3 North America Edaravone Market Size by Country
7.3.1 North America Edaravone Sales in Volume by Country (2016-2026)
7.3.2 North America Edaravone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Edaravone Sales by Type (2016-2026)
8.2 Europe Edaravone Sales by Application (2016-2026)
8.3 Europe Edaravone Market Size by Country
8.3.1 Europe Edaravone Sales in Volume by Country (2016-2026)
8.3.2 Europe Edaravone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Edaravone Sales by Type (2016-2026)
9.2 Asia-Pacific Edaravone Sales by Application (2016-2026)
9.3 Asia-Pacific Edaravone Market Size by Region
9.3.1 Asia-Pacific Edaravone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Edaravone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Edaravone Sales by Type (2016-2026)
10.2 South America Edaravone Sales by Application (2016-2026)
10.3 South America Edaravone Market Size by Country
10.3.1 South America Edaravone Sales in Volume by Country (2016-2026)
10.3.2 South America Edaravone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Edaravone Sales by Type (2016-2026)
11.2 Middle East & Africa Edaravone Sales by Application (2016-2026)
11.3 Middle East & Africa Edaravone Market Size by Country
11.3.1 Middle East & Africa Edaravone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Edaravone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Edaravone Typical Distributors
12.3 Edaravone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Edaravone Revenue by Type, (USD Million), 2021-2026
Table 2. Global Edaravone Revenue by Application, (USD Million), 2021-2026
Table 3. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Mitsubishi Tanabe Pharma Major Business
Table 5. Mitsubishi Tanabe Pharma Edaravone Product and Services
Table 6. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Simcere Basic Information, Manufacturing Base and Competitors
Table 8. Simcere Major Business
Table 9. Simcere Edaravone Product and Services
Table 10. Simcere Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Taj Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. Taj Pharmaceuticals Ltd. Major Business
Table 13. Taj Pharmaceuticals Ltd. Edaravone Product and Services
Table 14. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharmaceutical Industries Ltd. Major Business
Table 17. Sun Pharmaceutical Industries Ltd. Edaravone Product and Services
Table 18. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Unichem Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Unichem Laboratories Ltd Major Business
Table 21. Unichem Laboratories Ltd Edaravone Product and Services
Table 22. Unichem Laboratories Ltd Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. UCB India Ltd Basic Information, Manufacturing Base and Competitors
Table 24. UCB India Ltd Major Business
Table 25. UCB India Ltd Edaravone Product and Services
Table 26. UCB India Ltd Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Piramal Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Piramal Healthcare Major Business
Table 29. Piramal Healthcare Edaravone Product and Services
Table 30. Piramal Healthcare Edaravone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Edaravone Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Edaravone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Edaravone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Edaravone Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Edaravone Production Site of Key Manufacturer
Table 36. Global Edaravone Sales by Region (2016-2021e) & (K Units)
Table 37. Global Edaravone Sales by Region (2021-2026) & (K Units)
Table 38. Global Edaravone Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Edaravone Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Edaravone Sales by Type (2016-2021e) & (K Units)
Table 41. Global Edaravone Sales by Type (2021-2026) & (K Units)
Table 42. Global Edaravone Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Edaravone Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Edaravone Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global Edaravone Price by Type (2021-2026) & (USD/Unit)
Table 46. Global Edaravone Sales by Application (2016-2021e) & (K Units)
Table 47. Global Edaravone Sales by Application (2021-2026) & (K Units)
Table 48. Global Edaravone Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Edaravone Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Edaravone Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global Edaravone Price by Application (2021-2026) & (USD/Unit)
Table 52. North America Edaravone Sales by Country (2016-2021e) & (K Units)
Table 53. North America Edaravone Sales by Country (2021-2026) & (K Units)
Table 54. North America Edaravone Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Edaravone Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Edaravone Sales by Type (2016-2021e) & (K Units)
Table 57. North America Edaravone Sales by Type (2021-2026) & (K Units)
Table 58. North America Edaravone Sales by Application (2016-2021e) & (K Units)
Table 59. North America Edaravone Sales by Application (2021-2026) & (K Units)
Table 60. Europe Edaravone Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Edaravone Sales by Country (2021-2026) & (K Units)
Table 62. Europe Edaravone Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Edaravone Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Edaravone Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Edaravone Sales by Type (2021-2026) & (K Units)
Table 66. Europe Edaravone Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Edaravone Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Edaravone Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Edaravone Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Edaravone Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Edaravone Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Edaravone Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Edaravone Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Edaravone Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Edaravone Sales by Application (2021-2026) & (K Units)
Table 76. South America Edaravone Sales by Country (2016-2021e) & (K Units)
Table 77. South America Edaravone Sales by Country (2021-2026) & (K Units)
Table 78. South America Edaravone Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Edaravone Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Edaravone Sales by Type (2016-2021e) & (K Units)
Table 81. South America Edaravone Sales by Type (2021-2026) & (K Units)
Table 82. South America Edaravone Sales by Application (2016-2021e) & (K Units)
Table 83. South America Edaravone Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Edaravone Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Edaravone Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Edaravone Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Edaravone Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Edaravone Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Edaravone Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Edaravone Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Edaravone Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Edaravone Typical Distributors
Table 95. Edaravone Typical Customers
List of Figures
Figure 1. Edaravone Picture
Figure 2. Global Edaravone Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Edaravone Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Edaravone Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Edaravone Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Edaravone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Edaravone Sales (2016-2026) & (K Units)
Figure 31. Global Edaravone Production Capacity (2016-2026) & (K Units)
Figure 32. Global Edaravone Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Edaravone Market Drivers
Figure 34. Edaravone Market Restraints
Figure 35. Edaravone Market Trends
Figure 36. Global Edaravone Sales Market Share by Manufacturer in 2020
Figure 37. Global Edaravone Revenue Market Share by Manufacturer in 2020
Figure 38. Edaravone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Edaravone Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Edaravone Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Edaravone Sales Market Share by Region (2016-2026)
Figure 42. Global Edaravone Revenue Market Share by Region (2016-2026)
Figure 43. North America Edaravone Revenue (2016-2026) & (USD Million)
Figure 44. Europe Edaravone Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Edaravone Revenue (2016-2026) & (USD Million)
Figure 46. South America Edaravone Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Edaravone Revenue (2016-2026) & (USD Million)
Figure 48. Global Edaravone Sales Market Share by Type (2016-2026)
Figure 49. Global Edaravone Revenue Market Share by Type (2016-2026)
Figure 50. Global Edaravone Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Edaravone Sales Market Share by Application (2016-2026)
Figure 52. Global Edaravone Revenue Market Share by Application (2016-2026)
Figure 53. Global Edaravone Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Edaravone Sales Market Share by Country (2016-2026)
Figure 55. North America Edaravone Revenue Market Share by Country (2016-2026)
Figure 56. North America Edaravone Sales Market Share by Type (2016-2026)
Figure 57. North America Edaravone Sales Market Share by Application (2016-2026)
Figure 58. Europe Edaravone Sales Market Share by Country (2016-2026)
Figure 59. Europe Edaravone Revenue Market Share by Country (2016-2026)
Figure 60. Europe Edaravone Sales Market Share by Type (2016-2026)
Figure 61. Europe Edaravone Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Edaravone Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Edaravone Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Edaravone Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Edaravone Sales Market Share by Application (2016-2026)
Figure 66. South America Edaravone Sales Market Share by Country (2016-2026)
Figure 67. South America Edaravone Revenue Market Share by Country (2016-2026)
Figure 68. South America Edaravone Sales Market Share by Type (2016-2026)
Figure 69. South America Edaravone Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Edaravone Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Edaravone Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Edaravone Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Edaravone Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の筋萎縮性側索硬化症（ALS）治療薬市場規模・現状・予測（2021年-2027年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の口腔内溶解フィルム市場 2021：企業別、地域別、種類・用途別 The Oral Dissolvable Films market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …